President Donald Trump told The New York Times he has not used GLP-1 weight-loss drugs like Ozempic or Wegovy but joked he “probably should.” The disclosure comes as these medications spark debates over healthcare costs and insurance coverage. Trump’s remarks highlight both his personal health and his administration’s policies aimed at lowering drug prices, showing the drugs’ growing political and cultural relevance.
